45 matches.
- New HIPAA Final Rule: Key Changes to Reproductive Health Care Privacy
- The DEA Is Knocking at Your Door . . . Are You Prepared?
- The Future of Laboratory Testing Just Got a Little Clearer: FDA's Final Rule on LDTs
- If Cannabis Is Reclassified, What Will Happen to the Marketplace?
- Unveiling Gender-Affirming Care: Why It Matters and What’s at Stake
- Litigating Nutrition: Class Action Battles Over Dietary Supplements
- FDA Releases Laboratory-Developed Tests Final Rule
- Braidwood v. Becerra: Challenging the Affordable Care Act’s Preventive Services Coverage Provision
- Dietary Supplements: Navigating the Regulatory Maze
- Game-Changing IRA: Revolutionizing Prescription Drug Pricing and Medicare Benefits
- Direct Access Laboratory Testing: Future FDA Proposed Regulations on LDTs
- Inflation Reduction Act’s Drug Price Negotiation Provisions – What Now?
- Post-Dobbs: One Year Later
- Managing Trade Secrets and Restrictive Covenants in Health Care M&A Deals
- The Legal Battle Over Mifepristone
- Inflation Reduction Act’s Drug Price Negotiation Provisions – What’s Next?
- Direct Access Laboratory Testing: Physician Orders and Specimen Collection
- Legal and Regulatory Landscape for Psychedelics as Therapies
- Direct Access Laboratory Testing: Reimbursement & Compliance
- Direct Access Laboratory Testing: Navigating the Regulatory Landscape
- Unpacking FDA's Final Clinical Decision Support Guidance
- 2023 Health Policy Outlook
- Post-Dobbs: Access to Reproductive Health Care and Abortion-Inducing Drugs
- Health Care's Past, Present, and Future
- Impact of COVID-19 on Pharmacist Scope of Practice: Before and After the PREP Act
- Career Pathways: Attorney Brad Thompson – Commitment to Lifelong Learning
- Entrepreneurship in Biotech: Growing Your Business
- Record-Shattering Year for FCA Recoveries in Health Care
- How Can Companies in the Health Care and Life Sciences Industries Strengthen Their Cybersecurity Posture?
- Federal and State Cannabis Rules Are Moving in Different Directions
- President Biden’s Use of the Defense Production Act
- COVID-19 Vaccines: The Ethical and Legal Challenges to Immunization
- The Biden Administration's First 100 Days
- Key Considerations for Reshoring U.S. Drug Manufacturing
- Product Launching in the Era of COVID-19
- Holding Pattern: Cannabis Industry Waits for FDA Regulatory Rulemaking
- Health Care Continues to Drive False Claims Act Recoveries: Thought Leaders in Health Law Video Series
- Trends in Cybersecurity of Medical Devices: Thought Leaders in Health Law Video Series
- Trends and Legal Risks in Medical Marijuana: Thought Leaders in Health Law Video Series
- Industry Implications of AI: Thought Leaders in Health Law Video Series
- Trends in TRICARE: Thought Leaders in Health Law Video Series
- Trends in Precision Medicine: Thought Leaders in Health Law Video Series
- Trends in Enforcement of Dietary Supplements: Thought Leaders in Health Law Video Series
- Trends in Fraud and Abuse in Home Care: Thought Leaders in Health Law Video Series
- Health Care Trends and Policies Impacted by the 2016 Elections: Thought Leaders in Health Law Video Series